Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Beam Therapeutics (BEAM) Preferred Shares Issued (2019)

Beam Therapeutics (BEAM) has disclosed Preferred Shares Issued for 1 consecutive years, with $37.9 million as the latest value for Q1 2019.

  • On a quarterly basis, Preferred Shares Issued changed N/A to $37.9 million in Q1 2019 year-over-year; TTM through Dec 2019 was $37.9 million, a N/A change, with the full-year FY2019 number at $37.9 million, changed N/A from a year prior.
  • Preferred Shares Issued was $37.9 million for Q1 2019 at Beam Therapeutics.
  • In the past five years, Preferred Shares Issued ranged from a high of $37.9 million in Q1 2019 to a low of $37.9 million in Q1 2019.